Secondary polycythemia in acutely ill COVID-19 patients is associated with higher mortality but not markedly higher thrombotic risk

References

• Lucijanic M, Tjesic-Drinkovic I, Piskac Zivkovic N, et al. Incidence, risk factors and mortality associated with major bleeding events in hospitalized COVID-19 patients. Life. 2023;13(8):1699. doi: 10.3390/life13081699.
   PubMedGoogle Scholar
• Jurin I, Lucijanić M, Piskač Živković N, et al. Incidence and risk factors for venous and arterial thromboses in hospitalized patients with coronavirus disease 2019: data on 4014 patients from a Tertiary Center Registry. Croat Med J. 2022;63(1):16–26. doi: 10.3325/cmj.2022.63.16.
   PubMed Web of Science ®Google Scholar
• Piskač Živković N, Lucijanić M, Bušić N, et al. The associations of age, sex, and comorbidities with survival of hospitalized patients with coronavirus disease 2019: data from 4014 patients from a Tertiary-Center Registry. Croat Med J. 2022;63(1):36–43. doi: 10.3325/cmj.2022.63.36.
   PubMed Web of Science ®Google Scholar
• Leiva O, Campia U, Snyder J, et al. Patients with myeloproliferative neoplasms and COVID-19 have increased rates of arterial thrombosis. Res Pract Thromb Haemost. 2022;6(5):e12752. doi: 10.1002/rth2.12752.
   PubMed Web of Science ®Google Scholar
• Barbui T, Iurlo A, Masciulli A, et al. Second versus first wave of COVID-19 in patients with MPN. Leukemia. 2022;36(3):897–900. doi: 10.1038/s41375-022-01507-2.
   PubMed Web of Science ®Google Scholar
• Barbui T, Vannucchi AM, Alvarez-Larran A, et al. High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib. Leukemia. 2021;35(2):485–493. doi: 10.1038/s41375-020-01107-y.
   PubMed Web of Science ®Google Scholar
• Lucijanic M, Kusec R. Ruxolitinib withdrawal due to the COVID-19. Leukemia. 2021;35(4):1218. doi: 10.1038/s41375-021-01214-4.
   PubMed Web of Science ®Google Scholar
• Lucijanic M, Krecak I, Soric E, et al. Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism. Blood Cancer J. 2021;11(11):189. doi: 10.1038/s41408-021-00585-2.
   PubMed Web of Science ®Google Scholar
• Lucijanić M, Piskač Živković N, Zelenika M, et al. Survival after hospital discharge in patients hospitalized for acute coronavirus disease 2019: data on 2586 patients from a Tertiary Center Registry. Croat Med J. 2022;63(4):335–342. doi: 10.3325/cmj.2022.63.335.
   PubMed Web of Science ®Google Scholar
• Barbui T, Iurlo A, Masciulli A, et al. Long-term follow-up of recovered MPN patients with COVID-19. Blood Cancer J. 2021;11(6):115. doi: 10.1038/s41408-021-00509-0.
   PubMed Web of Science ®Google Scholar
• Krečak I, Holik H, Zekanović I, et al. Thrombotic risk in secondary polycythemia resembles low-risk polycythemia vera and increases in specific subsets of patients. Thromb Res. 2022;209:47–50. doi: 10.1016/j.thromres.2021.11.025.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Clinical management of COVID-19: interim guidance. Geneva: World Health Organization; 2020.
   Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi: 10.1016/0021-9681(87)90171-8.
   PubMedGoogle Scholar
• Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649–656. doi: 10.1097/00000421-198212000-00014.
   PubMed Web of Science ®Google Scholar
• Kaatz S, Ahmad D, Spyropoulos AC, et al. Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH. J Thromb Haemost. 2015;13(11):2119–2126. doi: 10.1111/jth.13140.
   PubMed Web of Science ®Google Scholar
• Duarte K, Monnez JM, Albuisson E, et al. Prognostic value of estimated plasma volume in heart failure. JACC Heart Fail. 2015;3(11):886–893. doi: 10.1016/j.jchf.2015.06.014.
   PubMed Web of Science ®Google Scholar
• Lucijanic M, Krecak I, Busic I, et al. Estimated plasma volume status in COVID-19 patients and its relation to comorbidities and clinical outcomes. J Thromb Thrombolysis. 2023;57(1):50–57. doi: 10.1007/s11239-023-02882-y.
   PubMed Web of Science ®Google Scholar
• Lucijanic M, Krecak I, Cicic D, et al. Hypoosmolar and hyperosmolar COVID-19 patients are predisposed to dismal clinical outcomes. Scand J Clin Lab Invest. 2023;83(6):397–402.
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi: 10.7326/0003-4819-150-9-200905050-00006.
   PubMed Web of Science ®Google Scholar
• Cappellini MD, Motta I. Anemia in clinical practice—definition and classification: does hemoglobin change with aging? Semin Hematol. 2015;52(4):261–269. doi: 10.1053/j.seminhematol.2015.07.006.
   PubMed Web of Science ®Google Scholar
• Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization Classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–2405. doi: 10.1182/blood-2016-03-643544.
   PubMed Web of Science ®Google Scholar
• Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) Classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114(5):937–951. doi: 10.1182/blood-2009-03-209262.
   PubMed Web of Science ®Google Scholar
• Maheshwari A, Priya G, Bajpai M. Isolated erythrocytosis: a consequence of COVID-19 induced hypoxia. Int J Lab Hematol. 2022;44(1):e44–e45. doi: 10.1111/ijlh.13699.
   PubMed Web of Science ®Google Scholar
• Chi G, Gibson CM, Hernandez AF, et al. Association of anemia with venous thromboembolism in acutely ill hospitalized patients: an APEX trial substudy. Am J Med. 2018;131(8):972.e1–972.e7. doi: 10.1016/j.amjmed.2018.03.031.
   PubMed Web of Science ®Google Scholar
• Martins-Gonçalves R, Hottz ED, Bozza PT. Acute to post-acute COVID-19 thromboinflammation persistence: mechanisms and potential consequences. Curr Res Immunol. 2023;4:100058. doi: 10.1016/j.crimmu.2023.100058.
   PubMedGoogle Scholar